Our R&D Approach

Our research mission is simple: innovations that improve the quality of life of people everywhere. That motivation keeps us at the forefront of the Healthcare, Life Science and Performance Materials industries.

Healthcare R&D

Our research scientists are hard at work on groundbreaking medicines and technologies to treat everything from cancer, multiple sclerosis and infertility to colds and pains. Wherever there is a medical need, our highly experienced research and development team hopes to meet it. Learn more



R&D focus: Taking on the world’s most challenging medical conditions

As a science-driven organization, we are delivering a transformative pipeline that makes a real difference for patients, with a strong focus on helping to create, improve and prolong lives. Our core areas of research include:

  • Immunology ?
  • Oncology
  • Immuno-Oncology ?

In addition to our pipeline, we also deliver growth via support and thoughtful life cycle management for our existing fertility, immunology, and oncology franchises.

We are delivering innovation through a balance of internal expertise and external collaboration. We look for partners who share our passion for discovery and whose strengths complement our pipeline, strengthen our technology base and enhance our overall scientific capabilties.

Allergopharma – Allergen Immunotherapy

Allergopharma – Allergen Immunotherapy

R&D focus: Diagnosing and treating allergies

Our Allergopharma team includes some of the world’s leading specialists on allergies and how to treat them. They are constantly developing innovative therapies and diagnosis strategies to tackle this widespread condition, with research focused in the following areas:

  • Immunology?Molecular allergology?
  • Biotechnology?
  • Analytical methods?
  • Clinical research?

Life Science R&D

R&D focus: Reimagining new ways to meet the needs of our customers

Innovation is at the core of the value that we deliver to our customers. Our Life Science business is research driven and innovation focused. In 2016, we invested 260 million Euro in R&D which supported our innovation in launching 2,100 products – products designed to meet our customers' most unmet needs – from antibodies to water purification systems.

The ability to innovate is the core of our culture across all three of our businesses; Research Solutions, Process Solutions and Applied Solutions. Learn more

Performance Materials R&D

R&D focus: Keeping the world’s performance materials on the cutting edge

Our performance materials business is an innovation leader, constantly producing new technologies and new markets for our customers, often through partnerships across industries. We have come up with groundbreaking liquid crystal displays and windows, effect pigments for coatings and color cosmetics and high-tech materials for use in integrated circuits. Learn more


You have accessed?http://www.wucnuv.live, but for users from your part of the world, we originally designed the following web presence?https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our?Privacy Statement.?